NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRXP NRX Pharmaceuticals Inc.

交易中 02-27 13:04:26 EST

1.89

-0.04

-2.33%

最高1.93	最低1.87	成交量29.85万
今开1.90	昨收1.93	日振幅3.11%
总市值6,008万	流通市值4,351万	总股本3,187万
成交额56.53万	换手率1.29%	流通股本2,308万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":1.885,"timestamp":1772215438370,"preClose":1.93,"halted":0,"volume":298478,"delay":0,"changeRate":-0.023316062176165768,"floatShares":23082300,"shares":31872300,"eps":-2.31,"marketStatus":"交易中","change":-0.045,"latestTime":"02-27 13:04:26 EST","open":1.9,"high":1.93,"low":1.87,"amount":565274.7988849999,"amplitude":0.031088,"askPrice":1.89,"askSize":372,"bidPrice":1.88,"bidSize":178,"shortable":3,"etf":0,"ttmEps":-2.31,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772226000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.93,"preHourTrading":{"tag":"盘前","latestPrice":1.92,"preClose":1.93,"latestTime":"09:19 EST","volume":3928,"amount":7738.689887199999,"timestamp":1772201974220,"change":-0.01,"changeRate":-0.005181,"amplitude":0.072539},"postHourTrading":{"tag":"盘后","latestPrice":1.94,"preClose":1.93,"latestTime":"19:56 EST","volume":3265,"amount":6332.215,"timestamp":1772153780236,"change":0.01,"changeRate":0.005181,"amplitude":0.015544},"volumeRatio":0.756312,"impliedVol":0.4708,"impliedVolPercentile":0.0398},"requestUrl":"/m/hq/s/NRXP","defaultTab":"news","newsList":[{"id":"1169441002","title":"NRX制药将结合现有临床试验数据与Osmind拟议真实世界数据 申请NRX-100获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1169441002","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169441002?lang=zh_cn&edition=full","pubTime":"2026-02-17 20:16","pubTimestamp":1771330590,"startTime":"0","endTime":"0","summary":"NRX制药公司宣布，计划整合其掌握的临床试验数据与Osmind平台提供的拟议真实世界证据，共同向监管机构提交NRX-100的上市申请。这一策略旨在通过传统研究数据与真实临床实践数据的互补，强化该药物治疗方案的论证基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"1158312824","title":"NRX Pharmaceuticals Inc.（纳斯达克：NRXP）发布2025年第三季度财务业绩并提供公司更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1158312824","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158312824?lang=zh_cn&edition=full","pubTime":"2025-11-17 21:03","pubTimestamp":1763384590,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals Inc.（纳斯达克：NRXP）发布2025年第三季度财务业绩并提供公司更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"1137118171","title":"Hope Therapeutics, Inc. 与 Ampa Health 合作，在佛罗里达州首次启动一天（One-D）抑郁症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1137118171","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137118171?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:06","pubTimestamp":1762779970,"startTime":"0","endTime":"0","summary":"Hope Therapeutics, Inc. 与 Ampa Health 合作，在佛罗里达州首次启动一天（One-D）抑郁症治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"1140234845","title":"霍普治疗公司与NRX制药公司宣布佛罗里达州萨拉索塔的Cohen & Associates, Llc加入霍普网络，并任命Rebecca Cohen博士为霍普医疗主任","url":"https://stock-news.laohu8.com/highlight/detail?id=1140234845","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140234845?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:04","pubTimestamp":1760961849,"startTime":"0","endTime":"0","summary":"霍普治疗公司与NRX制药公司（纳斯达克代码：NRXP）宣布，佛罗里达州萨拉索塔的Cohen & Associates, Llc正式加入霍普网络，同时任命Rebecca Cohen博士为霍普医疗主任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"1181024029","title":"Hope Therapeutics, Inc.与NRX Pharmaceuticals Inc.（纳斯达克：NRXP）完成收购Dura Medical；干预性精神病学诊所网络的首次收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1181024029","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181024029?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:18","pubTimestamp":1757333895,"startTime":"0","endTime":"0","summary":"Hope Therapeutics, Inc.与NRX Pharmaceuticals Inc.（纳斯达克：NRXP）完成收购Dura Medical；干预性精神病学诊所网络的首次收购","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2512485964","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大跌5.15%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512485964?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:03","pubTimestamp":1739977417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时03分，Nrx Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报2.58美元/股，成交量11.7498万股，换手率0.69%，振幅8.72%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230338a24c02d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230338a24c02d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2512964391","title":"Nrx Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.26%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512964391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512964391?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:18","pubTimestamp":1739906325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时18分，Nrx Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.26%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031845abd3e9dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031845abd3e9dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2510082333","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.94%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510082333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510082333?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:05","pubTimestamp":1739286321,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时05分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.94%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112305219881c3bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112305219881c3bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","NRXP","BK4007","BK4139"],"gpt_icon":0},{"id":"2509744248","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744248?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:44","pubTimestamp":1738939494,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时44分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.03%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224454a23d266e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224454a23d266e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2509358172","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509358172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509358172?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:53","pubTimestamp":1738770825,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时53分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.58%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235345961917ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235345961917ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2508214081","title":"Nrx Pharmaceuticals, Inc.盘中异动 大幅拉升5.30%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508214081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508214081?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:48","pubTimestamp":1738597719,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时48分，Nrx Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.30%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为555.30%、425.10%、352.43%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为158.16%、75.23%、53.59%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032348399617085a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032348399617085a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2508975189","title":"Nrx Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508975189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508975189?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:50","pubTimestamp":1738356612,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时50分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.02%。截至发稿，该股报3.14美元/股，成交量34.3327万股，换手率2.03%，振幅8.03%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045012abbe7bf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045012abbe7bf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2507216076","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.05%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507216076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507216076?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:36","pubTimestamp":1738247762,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时36分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速下跌6.05%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223602a234561f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223602a234561f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2507631922","title":"Nrx Pharmaceuticals, Inc.盘中异动 快速下跌5.97%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507631922?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:38","pubTimestamp":1738161494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时38分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.97%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922381498760ad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922381498760ad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","NRXP","BK4007","BK4139"],"gpt_icon":0},{"id":"2506146825","title":"Nrx Pharmaceuticals, Inc.股价上涨10.14% 市值涨36.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506146825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506146825?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074696,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨10.14%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313698756b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313698756b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2506305472","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506305472?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:02","pubTimestamp":1737990125,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时02分，Nrx Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.28%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127230206a231713a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127230206a231713a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2505459230","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.03%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505459230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505459230?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:11","pubTimestamp":1737648710,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时11分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.03%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001150960e5847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001150960e5847&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2505221237","title":"Nrx Pharmaceuticals, Inc.盘中异动 大幅上涨5.38%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505221237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505221237?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:40","pubTimestamp":1737560414,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时40分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.38%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122234015960d0af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122234015960d0af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2505951271","title":"Nrx Pharmaceuticals, Inc.盘中异动 大幅下跌5.24%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505951271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505951271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:35","pubTimestamp":1737470124,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时35分，Nrx Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.24%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223524986e3398&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223524986e3398&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2504640971","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大跌5.40%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504640971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504640971?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:44","pubTimestamp":1737125058,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时44分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.40%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117224419986a1856&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117224419986a1856&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.salbergco.com","stockEarnings":[{"period":"1week","weight":0.0489},{"period":"1month","weight":-0.1384},{"period":"3month","weight":-0.2122},{"period":"6month","weight":-0.1681},{"period":"1year","weight":-0.2058},{"period":"ytd","weight":-0.2878}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0089},{"period":"3month","weight":0.0086},{"period":"6month","weight":0.0686},{"period":"1year","weight":0.1594},{"period":"ytd","weight":0.0108}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NRX Therapeutics, Inc.是于2015年5月20日依照特拉华州法律成立的公司。该公司是一家临床阶段的生物制药公司，该公司通过其全资运营子公司NeuroRx, Inc.开发和分销用于治疗中枢神经系统疾病（包括自杀性抑郁症、慢性疼痛、创伤后应激障碍以及现在的精神分裂症）的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.074525},{"month":2,"riseRate":0.2,"avgChangeRate":-0.096099},{"month":3,"riseRate":0.25,"avgChangeRate":-0.079214},{"month":4,"riseRate":0.25,"avgChangeRate":-0.225146},{"month":5,"riseRate":0.75,"avgChangeRate":0.071255},{"month":6,"riseRate":0.4,"avgChangeRate":-0.166652},{"month":7,"riseRate":0.4,"avgChangeRate":0.039708},{"month":8,"riseRate":0.2,"avgChangeRate":-0.14211},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012776},{"month":10,"riseRate":0.6,"avgChangeRate":0.037482},{"month":11,"riseRate":0.4,"avgChangeRate":0.048439},{"month":12,"riseRate":0.6,"avgChangeRate":0.121824}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc.","nameEN":"NRX Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NRX Pharmaceuticals Inc.,NRXP,NRX Pharmaceuticals Inc.股票,NRX Pharmaceuticals Inc.股票老虎,NRX Pharmaceuticals Inc.股票老虎国际,NRX Pharmaceuticals Inc.行情,NRX Pharmaceuticals Inc.股票行情,NRX Pharmaceuticals Inc.股价,NRX Pharmaceuticals Inc.股市,NRX Pharmaceuticals Inc.股票价格,NRX Pharmaceuticals Inc.股票交易,NRX Pharmaceuticals Inc.股票购买,NRX Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}